Chancellor Reeves Plans Specific Action on Living Costs in Forthcoming Budget
Chancellor Reeves has stated she is planning "specific measures to tackle household expense pressures" in next month's financial statement.
In comments to media outlets, she emphasized that reducing inflation is a collective task of both the administration and the Bank of England.
The United Kingdom's price growth is expected to be the highest among the G7 industrialized countries this year and next.
Potential Energy Cost Measures
It is understood the government could take action to reduce energy bills, such as by reducing the present 5% rate of value-added tax applied on energy supplies.
An additional possibility is to lower some of the government charges currently added to bills.
Budgetary Limitations and Analyst Expectations
The administration will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.
The expectation from most analysts is that Reeves will have to declare tax rises or expenditure reductions in order to adhere to her voluntary fiscal targets.
Earlier on Thursday, analysis suggested there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of forecasts.
"There's a joint job between the Bank of England and the administration to bear down further on some of the sources of inflation," the Chancellor told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.
Revenue Pledges and International Concerns
While a great deal of the attention has been on likely tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her pledge to election pledges not to raise tax levels on earnings tax, sales tax or National Insurance.
She blamed an "uncertain world" with increasing geopolitical and trade issues for the Budget tax moves, likely to be focused on those "with the broadest shoulders."
International Economic Disputes
Commenting on apprehensions about the UK's economic relations with China she said: "Our security interests invariably are paramount."
Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other materials that are essential for advanced tech manufacturing led US President Donald Trump to threaten an extra 100% tariff on imports from the Asian country, increasing the risk of an all-out trade war between the two economic giants.
The US Treasury Secretary described the Chinese move "commercial pressure" and "a global supply chain control attempt."
Questioned on accepting the American proposal to join its dispute with China, Reeves said she was "very concerned" by China's measures and encouraged the Chinese government "to avoid restrictions and restrict access."
She said the move was "harmful for the global economy and creates additional headwinds."
"In my view there are areas where we need to confront Chinese policies, but there are also important opportunities to export to China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium appropriate."
The Treasury chief also stated she was working with international partners "on our own essential resources strategy, so that we are less reliant."
NHS Drug Costs and Funding
Reeves also acknowledged that the price the National Health Service pays for drugs could go up as a result of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and investment.
A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling operations in the United Kingdom, with some blaming the modest returns they are obtaining.
Last month, the Science Minister said the cost the health service pays for medicines would must go up to stop businesses and pharmaceutical investment leaving the United Kingdom.
Reeves stated to the BBC: "We have seen because of the pricing regime, that drug testing, new drugs have not been available in the UK in the extent that they are in other continental states."
"Our aim is to make sure that individuals receiving treatment from the NHS are able to receive the finest essential medicines in the world. And so we are reviewing these issues, and... looking to secure more capital into Britain."